---
title: "Manus Bio Inc. SEC filings"
url: https://altstreet.investments/edgar/1686230
kind: edgar-entity
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Manus Bio Inc.: SEC filings and what they report

| Field | Value |
| --- | --- |
| Entity | Manus Bio Inc. |
| CIK | 1686230 |
| Filing family | Form D |
| Total offering amount (as filed) | $11,270,003 |
| Total sold (as reported) | $11,270,003 |
| Investors (as reported) | 6 |

## Filings (8 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| May 14, 2024 | D | Form D | https://www.sec.gov/Archives/edgar/data/1686230/000092963824001779/ |
| May 31, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/1686230/000156761923006261/ |
| November 9, 2020 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1686230/000156761920018949/ |
| November 6, 2020 | D | Form D | https://www.sec.gov/Archives/edgar/data/1686230/000156761920018878/ |
| July 16, 2018 | D | Form D | https://www.sec.gov/Archives/edgar/data/1686230/000114036118032538/ |
| December 29, 2017 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1686230/000168623017000004/ |
| August 23, 2017 | D | Form D | https://www.sec.gov/Archives/edgar/data/1686230/000168623017000003/ |
| October 12, 2016 | D | Form D | https://www.sec.gov/Archives/edgar/data/1686230/000168623016000002/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1686230
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001686230&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1686230
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.